Clinical Trials Browser

Esophageal Neoplasms × Risk Assessment × Gastrointestinal × Clear all

NCT06306755 2025-01-24

ERSS-EGC

Phase NA Recruiting

21,000 enrolled

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms